FDA approves two combination AIDS drugs delivered in a single pill form

08/3/2004 | USA Today · NYTimes.com

The FDA gave its approval to two combination AIDS drugs, making it more likely that patients in poor countries will have access to treatment through the U.S.' $15 billion emergency AIDS fund. Both pills combine two medicines into one pill to be taken once a day. Gilead Science's Truvada combines Viread and Emtriva and GlaxoSmithKline's Epzicom combines the company's HIV medicines Epivir and Ziagen.

View Full Article in:

USA Today · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA